Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-26 @ 1:14 AM
NCT ID:
NCT02101034
Group ID:
EG002
Title:
Phase II Arm 1: Platin-Resistant HPV-Unrelated SCCHN
Description:
PD 0332991 125 mg per day will be administered on Days 1 through 21 of each 28 day cycle.
Cetuximab will be administered intravenously on a weekly schedule. The first dose will be 400 mg/m2. The remaining weekly dose will be 250 mg/m2. Participants will continue to receive weekly cetuximab at 250 mg/m2 for the duration of their participation on study.
Deaths Number Affected:
26
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
30
Other Number Affected:
30
Other Number At Risk:
30
Study:
NCT02101034
Results Section:
NCT02101034
Adverse Events Module:
NCT02101034